Skip to main content
Defiance International

Published study records

Study records for BPC-157

Study records describe published research and its limitations. They do not establish efficacy, safety, or suitability for any use.

Study record counts

329 study records.

4 evidence-verified · 293 citation-verified · 24 identifier-confirmed · 8 citation-only

Listed by tier, then records with a public summary first, then publication year, newest first, undated last.

Verified records by research setting

  • In vitro: 11
  • In vivo/preclinical: 239
  • Review/meta-analysis: 38
  • Other: 0
Filter study recordsReset filters

Filtered results

Study type: In vitro · Verification: Citation only

  • 2023

BPC-157 Dosage: Understanding the Basics for Optimal Results

Zenodo (CERN European Organization for Nuclear Research) · 2023

Study scale: Not reported in the declared source.

Bibliographic details only

No public summary

No plain-language summary is published in this record. Summary availability is separate from its verification. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation only. This record holds no current confirmation of its identifier at PubMed or Crossref. It is held as a citation, not evidence. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.

Study type: In vivo/preclinical · Verification: Citation only

  • 2022

Pentadecapeptide BPC 157 Anti‐Ulcer Effect After Stomach Perforation also Opposed the Intracranial Hypertension (Superior Sagittal Sinus), Portal and Caval Hypertension and Aortal Hypotension

The FASEB Journal · 2022

Study scale: Not reported in the declared source.

Bibliographic details only

No public summary

No plain-language summary is published in this record. Summary availability is separate from its verification. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation only. This record holds no current confirmation of its identifier at PubMed or Crossref. It is held as a citation, not evidence. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.

Study type: In vivo/preclinical · Verification: Citation only

  • 2022

Pentadecapeptide BPC 157 Counteracts Hemodynamic and ECG Disturbances Induced by Sotalol in Rats

The FASEB Journal · 2022

Study scale: Not reported in the declared source.

Bibliographic details only

No public summary

No plain-language summary is published in this record. Summary availability is separate from its verification. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation only. This record holds no current confirmation of its identifier at PubMed or Crossref. It is held as a citation, not evidence. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.

Study type: In vivo/preclinical · Verification: Citation only

  • 2022

FTIR Spectroscopy Reveals Molecular Changes in BPC 157 Treated Blood Vessels

The FASEB Journal · 2022

Study scale: Not reported in the declared source.

Bibliographic details only

No public summary

No plain-language summary is published in this record. Summary availability is separate from its verification. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation only. This record holds no current confirmation of its identifier at PubMed or Crossref. It is held as a citation, not evidence. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.

Study type: In vitro · Verification: Citation only

  • 2021

Novelties regarding pentadecapeptide BPC-157

Zenodo (CERN European Organization for Nuclear Research) · 2021

Study scale: Not reported in the declared source.

Bibliographic details only

No public summary

No plain-language summary is published in this record. Summary availability is separate from its verification. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation only. This record holds no current confirmation of its identifier at PubMed or Crossref. It is held as a citation, not evidence. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.